Smithwood Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Smithwood Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-120,000	Closed	-$20.7M	–	29
2015 Q1	$20.7M	Buy	+120,000	New	+$17.6M	2.13%	15

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Smithwood Advisers's SLXP Position: Q2 2015 in Review

Smithwood Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 120,000 shares — an estimated $20.7M sold.

Smithwood Advisers first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $20.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Smithwood Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Smithwood Advisers sold 120,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $20.7M.
Smithwood Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Smithwood Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $20.7M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Smithwood Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.